Icosavax, Inc.
ICVX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $387,738 | $444,574 | $239,334 | $316,102 |
| - Cash | $63,239 | $155,073 | $49,341 | $58,846 |
| + Debt | $8,071 | $8,441 | $8,798 | $8,795 |
| Enterprise Value | $332,570 | $297,942 | $198,791 | $266,051 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$763 | -$665 | -$643 | -$1,602 |
| % Margin | – | – | – | – |
| EBITDA | -$25,275 | -$28,955 | -$24,561 | -$25,131 |
| % Margin | – | – | – | – |
| Net Income | -$22,041 | -$26,497 | -$22,600 | -$21,480 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.44 | -0.59 | -0.55 | -0.54 |
| % Growth | 25.4% | -7.3% | -1.9% | – |
| Operating Cash Flow | -$18,972 | -$19,222 | -$21,649 | -$9,004 |
| Capital Expenditures | -$32 | -$679 | -$1,573 | -$2,550 |
| Free Cash Flow | -$19,004 | -$19,901 | -$23,222 | -$11,554 |